NHP Stock Forecast & Price Target

National Healthcare is positioned to benefit from a deliberate shift toward a higher-growth SHOP-heavy portfolio, with management actively recycling capital out of lower-growth OMF assets and into middle-market senior housing where competition is muted and yields are more attractive. Operationally, the SHOP portfolio is already showing strong momentum, with same-store cash NOI up 20.1% yr/yr, occupancy at 84.1%, and RevPOR up 5.9%, while full-year 2026 SHOP same-store cash NOI guidance was raised to 15.0%-18.0%. The balance sheet has also strengthened materially, with net debt to annualized adjusted EBITDA down to 4.6x, $1B of liquidity, and expected asset sales and acquisitions supporting core FFO/FAD growth into 2027 and 2028.

National Healthcare is viewed negatively because its earnings depend heavily on senior housing fundamentals that may plateau, while older middle-market assets are expected to produce only muted mid- to high-single-digit growth and more volatile occupancy. The shift from OMF toward SHOP adds execution risk, since the company must dispose of assets and redeploy capital at comparable or higher yields, yet same-store OMF cash NOI already declined 40 bps year over year to $20.2 million and AFFO could fall 10%. Added pressure comes from likely external capital needs, a ~$400 million legacy shareholder lock-up expiring in late October 2026, and regulatory, reimbursement, labor, and weather risks that could weaken cash flows and valuation.